# The TRUST Study - CardioVascular Imaging IMT

Study · id `cardio:ct-nct02832934` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02832934](<https://clinicaltrials.gov/study/NCT02832934>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02832934

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease; Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 184 participants.

## Technical summary

Registry record NCT02832934. Randomized; quadruple masking; primary purpose treatment. Start 2016-06 (registry gives no type); primary completion 2016-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 184 participants (enrolled count; ClinicalTrials.gov record NCT02832934, source copy `cardio:ctgov-nct02832934-2017-02-28`, retrieved 2026-10-26)
- Start date: 2016-06 (registry gives no type) (ClinicalTrials.gov record NCT02832934, source copy `cardio:ctgov-nct02832934-2017-02-28`, retrieved 2026-10-26)
- Primary completion: 2016-12 (actual) (ClinicalTrials.gov record NCT02832934, source copy `cardio:ctgov-nct02832934-2017-02-28`, retrieved 2026-10-26)
- Completion: 2016-12 (actual) (ClinicalTrials.gov record NCT02832934, source copy `cardio:ctgov-nct02832934-2017-02-28`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT02832934, source copy `cardio:ctgov-nct02832934-2017-02-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02832934-2017-02-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: The TRUST Study - CardioVascular Imaging IMT
- Condition: Thyroid Dysfunction
- Condition: Atherosclerosis
- Condition: Heart Failure
- Intervention (Drug): Levothyroxine
- Intervention (Drug): Placebo
- Lead sponsor: Insel Gruppe AG, University Hospital Bern
- Lead sponsor class: OTHER
- Collaborator: University of Lausanne Hospitals
- Collaborator class: OTHER
- Collaborator: University Hospital, Geneva
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Insel Gruppe AG, University Hospital Bern (`cardio:org-insel-gruppe-ag-university-hospital-bern`)
- Registry lists this organization as a collaborator: University of Lausanne Hospitals (`cardio:org-university-of-lausanne-hospitals`)
- Registry lists this organization as a collaborator: University Hospital, Geneva (`cardio:org-university-hospital-geneva`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized Trial (`cardio:pubmed-29846630`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b53388caa13ed46d1ea598169aaa59b285058f7023cb9d8d711be72925a3266e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
